EMA To Draw Up 'Critical Medicine' Lists For Future Health Crises
Industry Will Be ‘Invited’ To Review Product Lists
As part of its expanded mandate, the EU regulator is identifying those medicines whose supply will need to be closely monitored during health crisis situations. The lists will draw on various information sources, including real-world evidence databases.
You may also be interested in...
French Industry Chief On How To Encourage Innovation & Avoid Drug Shortages
Pricing challenges, high taxes and the growing problem of drug shortages have led the pharmaceutical industry body Leem to come forward with a set of proposals that it says should inform future government policy towards the sector.
EU Health Crisis Package Includes Supply Chain Revamps, Central Procurement & Regulatory Flexibility
The European Commission says that all the legislation for the creation of the European Health Union is now in place, following the publication of regulations on the supply and availability of medical countermeasures, centrally coordinated procurement mechanisms, and “ever-ready” manufacturing capacity for use in health emergencies.
EMA Publishes List Of ‘Critical’ COVID-19 Products
A steering group set up by the EU regulator has produced a list of five vaccines and nine therapeutics that it deems essential for use in preventing and treating COVID-19. It will also draw up a list of critical medicines for use in emergency and intensive care during health crises.